نتائج البحث - "CS, chitosan"

1

Delivery strategies of amphotericin B for invasive fungal infections

المؤلفون: Jun Wu, Li-Fang Fan, Zongmin Zhao, Imran Shair Mohammad, Lifang Yin, Xiaochun Wang, Zhongjian Chen, Marwa Ahmed Sallam, Wei He, Nurunnabi

المصدر: Acta Pharmaceutica Sinica. B
Acta Pharmaceutica Sinica B, Vol 11, Iss 8, Pp 2585-2604 (2021)

مصطلحات موضوعية: PEG-DSPE, PEG-lipid poly(ethylene glycol)-distearoylphosphatidylethanolamine, BUN, blood urea nitrogen, DMSA, dimercaptosuccinic acid, Review, CMC, carboxymethylated l-carrageenan, PVA, poly(vinyl alcohol), 0302 clinical medicine, Medicine, BDDE, butanediol diglycidyl ether, General Pharmacology, Toxicology and Pharmaceutics, media_common, 0303 health sciences, MFC, minimum fungicidal concentrations, P-407, poloxamer-407, PLGA, polyvinyl alcohol poly(lactic-co-glycolic acid), L-AmB, liposomal AmB, AmB-SD, AmB sodium deoxycholate, 030220 oncology & carcinogenesis, LNA, linolenic acid, MOP, microneedle ocular patch, Drug, Antifungal, medicine.medical_specialty, Aspergillus fumigatus, A. fumigatus, SEM, scanning electron microscope, media_common.quotation_subject, γ-PGA, γ-poly(gamma-glutamic acid, CLSM, confocal laser scanning microscope, PVP, polyvinylpyrrolidone, RM1-950, PEG-PUC, urea-functionalized polycarbonate/PEG, 03 medical and health sciences, Invasive fungal infections, Amphotericin B, AP, antisolvent precipitation, BBB, blood‒brain barrier, PLGA-PLH-PEG, PLGA-b-poly(l-histidine)-b-poly(ethylene glycol), Intensive care medicine, Topical administration, ARDS, acute respiratory distress syndrome, NPs, nanoparticles, AmB, amphotericin B, BCS, biopharmaceutics classification system, technology, industry, and agriculture, PDA, poly(glycolic acid), bacterial infections and mycoses, Nanoparticles, PDLLGA, poly(d,l-lactic-co-glycolic acid), RES, reticuloendothelial system, Future studies, ICV, intensive care unit, PGA-PPA, poly(l-lysine-b-l-phenylalanine) and poly(l-glutamic acid-b-l-phenylalanine), CS, chitosan, DMPC, dimyristoyl phosphatidyl choline, POR, porphyran, AmB-PM, AmB-polymeric micelles, γ-CD, γ-cyclodextrin, DDS, drug delivery systems, AmB-GCPQ, AmB-encapsulated N-palmitoyl-N-methyl-N,N-dimethyl-N,N,N-trimethyl-6-O-glycol-chitosan nanoparticles, MPEG-PCL, monomethoxy poly(ethylene glycol)-poly(epsilon-caprolactone), PAM, polyacrylamide, CFU, colony-forming unit, MAA, methacrylic acid, PEG, poly(ethylene glycol), IFIs, invasive fungal infections, PLA, poly(lactic acid), PMMA, poly(methyl methacrylate), PDLLA, poly(d,l-lactic acid), HPMC, hydroxypropyl methylcellulose, ARDs - Acute respiratory distress syndrome, PEG-PBC, phenylboronic acid-functionalized polycarbonate/PEG, Conjugates, AmBd, AmB deoxycholate, GNPs, gelatin nanoparticles, HPH, high-pressure homogenization, medicine.drug, AmB-IONP, AmB-loaded iron oxide nanoparticles, MIC, minimum inhibitory concentration, NLC, nanostructured lipid carriers, medicine.drug_class, PVP - Polyvinylpyrrolidone, DMPG, dimyristoyl phosphatidylglycerole, ROS, reactive oxygen species, NEs, nanoemulsions, MN, microneedles, parasitic diseases, 030304 developmental biology, Poor water-solubility, CP, chitosan-polyethylenimine, Toxicity, urogenital system, business.industry, ABCD, AmB colloidal dispersion, Public concern, SL-AmB, sophorolipid-AmB, PCL, polycaprolactone, SLNs, solid lipid nanoparticles, AIDS, acquired immunodeficiency syndrome, C. Albicans, Candida Albicans, Drug delivery, RBCs, red blood cells, BSA, bovine serum albumin, Therapeutics. Pharmacology, Nanocarriers, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::422a502aeaaad20f2253c2f7645ad654Test
https://doi.org/10.1016/j.apsb.2021.04.010Test

2

The influence of the gut microbiota on the bioavailability of oral drugs

المؤلفون: Ying Han, Xintong Zhang, Wei Huang, Zhonggao Gao, Mingji Jin

المصدر: Acta Pharmaceutica Sinica B, Vol 11, Iss 7, Pp 1789-1812 (2021)
Acta Pharmaceutica Sinica. B

مصطلحات موضوعية: SLC, solute carrier, Bioavailability, AMI, amiodarone, MPA, mycophenolic acid, TLCA, taurolithocholate, ASP, amisulpride, RA, rheumatoid arthritis, Review, NRs, nitroreductases, MDR1, multidrug resistance gene 1, NaGC, sodium glycholate, MATEs, multidrug and toxin extrusion proteins, NMEs, new molecular entities, 0302 clinical medicine, HFD, high fat diet, P-gp, P-glycoprotein, ACS, amphipathic chitosan derivative, Medicine, General Pharmacology, Toxicology and Pharmaceutics, LCA, lithocholic acid, 0303 health sciences, Gastrointestinal tract, IBD, inflammatory bowel disease, pKa, dissociation constant, RBC, red blood cell, FA, folate, OATs, organic anion transporters, 030220 oncology & carcinogenesis, MKC, monoketocholic acid, the GI tract, the gastrointestinal tract, AQP4, aquaporin 4, OCTNs, organic zwitterion/cation, T2D, type 2 diabetes, Gut microbiota, RM1-950, WHO, World Health Organization, 03 medical and health sciences, EcN, Escherichia coli Nissle 1917, Drug Transport Process, BDEPT, the bacteria-directed enzyme prodrug therapy, BCS, biopharmaceutics classification system, NEC, necrotizing enterocolitis, DRPs, digoxin reduction products, NaDC, sodium deoxycholate, Probiotics, CPP, cell-penetrating peptide, OCTs, organic cation transporters, TDCA, taurodeoxycholate, cgr operon, cardiac glycoside reductase operon, RA - Rheumatoid arthritis, DCA, deoxycholic acid, AA, ascorbic acid, BBR, berberine, Personalized medicine, BDDCS, the biopharmaceutics drug disposition classification system, SSZ, sulfasalazine, UDC, ursodeoxycholic acid, PPIs, proton pump inhibitors, BCRP, breast cancer resistance protein, CS, chitosan, Gut flora, Bioinformatics, PD, Parkinson's disease, SLN, solid lipid nanoparticle, SGLT-1, sodium-coupled glucose transporter 1, Oral administration, MRP2, multidrug resistance-associated protein 2, FAO, Food and Agriculture Organization of the United Nations, SVCT-1/2, the sodium-dependent vitamin C transporter-1/2, an OTC drug, an over-the-counter drug, CA, cholic acid, biology, ABC, ATP-binding cassette, T1DM, type 1 diabetes mellitus, NSAIDs, non-steroidal anti-inflammatory drugs, AR, azoreductase, GCDC, glycochenodeoxycholate, Drug delivery, GL, glycyrrhizic acid, PT, pectin, LPS, lipopolysaccharide, TME, the tumor microenvironment, T1D, type 1 diabetes, TCDC, taurochenodeoxycholate, Oral drugs, MDR1a, multidrug resistance protein-1a, SCFAs, short-chain fatty acids, CDCA, chenodeoxycholic acid, 030304 developmental biology, business.industry, dhBBR, dihydroberberine, biology.organism_classification, HTC, hematocrit, PWSDs, poorly water-soluble drugs, Colon-specific drug delivery system, stomatognathic diseases, SP, sulfapyridine, 5-ASA, 5-aminosalicylic acid, BSH, bile salt hydrolase, TCA, taurocholate, Therapeutics. Pharmacology, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d001e27a816f9de7d75ff16dd2143ecTest
http://www.sciencedirect.com/science/article/pii/S2211383520307279Test

3

Pharmaceutical strategies to extend pulmonary exposure of inhaled medicines

المؤلفون: Yi Guo, Mingshi Yang, Li Zhang, Changzhi Shi, Dongmei Cun, Hriday Bera

المصدر: Acta Pharmaceutica Sinica. B
Guo, Y, Bera, H, Shi, C, Zhang, L, Cun, D & Yang, M 2021, ' Pharmaceutical strategies to extend pulmonary exposure of inhaled medicines ', Acta Pharmaceutica Sinica B, vol. 11, no. 8, pp. 2565-2584 . https://doi.org/10.1016/j.apsb.2021.05.015Test
Acta Pharmaceutica Sinica B, Vol 11, Iss 8, Pp 2565-2584 (2021)

مصطلحات موضوعية: PLA, polylactic acid, MPP, mucus-penetrating particles, PLGA, poly(lactic-co-glycolic acid), Review, CS, chitosan, Pulmonary exposure, MW, molecular weight, PVA, polyvinyl alcohol, 0302 clinical medicine, Inhaled sustained release formulations, BALF, bronchoalveolar lavage fluid, General Pharmacology, Toxicology and Pharmaceutics, Patient compliance, COPD, chronic obstructive pulmonary diseases, HA, hyaluronic acid, DPIs, dry powder inhalers, 0303 health sciences, DPPC, dipalmitoylphosphatidylcholine, FDA, US food and drug administration, medicine.anatomical_structure, 030220 oncology & carcinogenesis, Obstructive Pulmonary Diseases, API, active pharmaceutical ingredient, NLCs, nanostructured lipid carriers, Clearance, medicine.medical_specialty, LABA, long-acting β2-adrenoceptor agonist, RM1-950, IL-5, interleukin-5, PCL, poly-ε-caprolactone, 03 medical and health sciences, LPPs, large porous particles, medicine, FDKP, fumaryl diketopiperazine, Intensive care medicine, Pharmaceutical strategies, Systemic diseases, Da, aerodynamic diameters, 030304 developmental biology, Asthma, PEG, polyethylene glycol, Lung, PVA - Polyvinyl alcohol, business.industry, DSPC, 1,2-distearoyl-sn-glycero-3-phosphocholine, Therapeutic effect, Drug administration, Pulmonary clearance pathways, MP, mucoadhesive particles, medicine.disease, Pulmonary drug delivery, SLNs, solid lipid nanoparticles, PDD, pulmonary drug delivery, Tmax, time of maximum concentration, ALIS, amikacin liposomal inhalation suspension, Mn, number-average molecular weight, MDIs, metered dose inhalers, Pulmonary safety, IL-4, interleukin-4, MCE, mucociliary escalator, PK, pharmacokinetics, Therapeutics. Pharmacology, ELF, epithelial lining fluid, business, Local lung diseases